News

News

Cognivia CEO Dominique Demolle, PhD, Named Among 2022’s Most Inspiring People by PharmaVoice

We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…

Read More
News

NEW Paper: Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials

Six Cognivia team members contribute critical elements to a recent paper published in Innovations in Clinical Neuroscience. Cognivia’s Erica…

Read More
News

New Cognivia article in Drug Development & Discovery on “Cracking Down on the Rising Costs of Drug Development”  

Drug development has changed significantly throughout the past 2 decades – including great leaps forward in areas from…

Read More
News

New Cognivia interview in Medical News Today on COVID-19 vaccines and ‘nocebo’ effect

New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…

Read More
News

New Cognivia article in Applied Clinical Trials on “Using Machine Learning to Predict Placebo Response and Increase Clinical Trial Success”

The overall risk of clinical trial failure is still too high – meaning more repeat trials, lost timelines…

Read More
News

New Cognivia publication on the use of composite covariates to understand complex data in clinical trial data analysis

Covariates are typically used to control for factors that may impact the measurement of outcomes, particularly to describe individual patient characteristics that may or may not relate to treatment response. In fact, all patient baseline characteristics collected are potential covariates linked with the patient’s outcome.

Read More